Dear Reader, Well that was a bizarre two months. We’ve gone from digesting what the coronavirus impact could look like, stock markets crashing, café tables being taken away from us, being shuttered indoors, to social unrest in two major financial hubs. What’s ahead for the next seven months of this year? Here in Australia, we’re […]
The biotech wars are only getting started. There’s no doubt that whatever country can create a COVID-19 vaccine first, will enjoy a huge economic advantage over competing countries. The race for a COVID-19 cure is shaping up to be just as important as the space race was in the ’60s…
Governments and central banks around the world are busy forestalling. The question is whether it’s the inevitable. Job losses, bankruptcies, mortgage defaults, corporate bond defaults, austerity or sovereign debt defaults, and plenty more. Does delaying them lead to avoiding them in the end? I’m not so sure, either way. But we’re going to find out […]
Another day, another biotech winner. The Acrux Ltd [ASX:ACR] share price is up 33.33% at time of writing. Surging on the back of confirmation of a new deal in the US. They’ve joined forces with private company TruPharma…
Dear Reader, Eroom’s Law. A cheeky spin on the traditional ‘Moore’s Law’ may be what’s behind the next ‘tech wonder stock’ of this decade. Ryan Dinse, editor of Money Morning and Exponential Stock Investor, made the bold call yesterday that the next ‘Google’ or ‘Apple’ or ‘Amazon’ wonder stock wasn’t going to be some tech […]
Remember when shelves at the supermarket were mostly empty?
Fat Tail Daily is brought to you by the team at Fat Tail Investment Research
Copyright © 2026 Fat Tail Daily | ACN: 117 765 009 / ABN: 33 117 765 009 / ASFL: 323 988
